| Issue Date | Title | Author(s) |
| 2020-08-06 | Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics. | Tan, YY; Yap, PK; Xin Lim, GL; Mehta, M; Chan, Y; Ng, SW; Kapoor, DN; Negi, P; Anand, K; Singh, SK; Jha, NK; Lim, LC; Madheswaran, T; Satija, S; Gupta, G; Dua, K; Chellappan, DK |
| 2021-09 | Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective | Chan, Y; Ng, SW; Singh, SK; Gulati, M; Gupta, G; Chaudhary, SK; Hing, GB; Collet, T; MacLoughlin, R; Löbenberg, R; Oliver, BG; Chellappan, DK; Dua, K |
| 2021-12 | Natural products in the management of obesity: Fundamental mechanisms and pharmacotherapy | Chan, Y; Ng, SW; Tan, JZX; Gupta, G; Negi, P; Thangavelu, L; Balusamy, SR; Perumalsamy, H; Yap, WH; Singh, SK; Caruso, V; Dua, K; Chellappan, DK |
| 2020-11-01 | Advanced drug delivery systems can assist in managing influenza virus infection: A hypothesis | Chan, Y; Ng, SW; Mehta, M; Anand, K; Kumar Singh, S; Gupta, G; Chellappan, DK; Dua, K |
| - | Nutraceuticals: unlocking newer paradigms in the mitigation of inflammatory lung diseases | Chan, Y; Raju Allam, VSR; Paudel, KR; Singh, SK; Gulati, M; Dhanasekaran, M; Gupta, PK; Jha, NK; Devkota, HP; Gupta, G; Hansbro, PM; Oliver, BGG; Chellappan, DK; Dua, K |
| 2021-07-31 | Introduction to Chronic Respiratory Diseases: A Pressing Need for Novel Therapeutic Approaches | Chan, Y; Ng, SW; Liew, HS; Pua, LJW; Soon, L; Lim, JS; Dua, K; Chellappan, DK |
| 2022 | Vesicular Drug Delivery Systems in Respiratory Diseases | Satija, S; Dhanjal, DS; Sharma, P; Hussain, MS; Chan, Y; Ng, SW; Prasher, P; Dureja, H; Chopra, C; Singh, R; Gupta, G; Chellappan, DK; Dua, K; Mehta, M |
| 2022-08 | Advances and applications of monoolein as a novel nanomaterial in mitigating chronic lung diseases. | Chan, Y; Singh, SK; Gulati, M; Wadhwa, S; Prasher, P; Kumar, D; Kumar, AP; Gupta, G; Kuppusamy, G; Haghi, M; George Oliver, BG; Adams, J; Chellappan, DK; Dua, K |
| 2022-11-11 | Recent Trends in rationally designed molecules as kinase inhibitors. | Prasher, P; Sharma, M; Chan, Y; Singh, SK; Anand, K; Dureja, H; Jha, NK; Gupta, G; Zacconi, F; Chellappan, DK; Dua, K |
| - | Applications and practice of advanced drug delivery systems for targeting Toll-like receptors in pulmonary diseases | Chan, Y; Prasher, P; Löbenberg, R; Gupta, G; Singh, SK; Oliver, BG; Chellappan, DK; Dua, K |
